We all fear the dreaded word dementia or Alzheimer's disease. This is understandable, especially considering the fact that two-thirds of all Alzheimer's patients and their caregivers are women. But how do you know if your forgetfulness is something …

Alzheimer's disease (AD) is a debilitating neurodegenerative disorder associated with a progressive decline in memory and mental abilities, which can significantly hinder people's ability to complete daily tasks. Past studies found that patients …

Partners in Aging, a Fredericksburg organization that focuses on resources for older adults and their families, recently presented Lori Myers with its Dr. Wayland Marks Gratitude Award. The honor goes to the person who best exemplifies the principle of …

New Delhi: A virus that can cause infection in the gut and from there travel to the brain, could be important in the development of Alzheimer's disease, according to a study. Existing antiviral drugs may then be looked at for treating or preventing …

Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug discovery of a phase I single ascending dose clinical trial of …

Scientists have discovered that Alzheimer's disease may be caused by a herpes virus that travels from the gut to the brain, potentially accounting for up to 45 per cent of cases. The breakthrough finding comes from US researchers who identified …

Women born in the most sexist US states experience a faster decline in memory performance after age 65 compared to those from less sexist regions, new research has revealed. The difference in cognitive decline between women from the most and least sexist …

New Delhi, Dec 20 (PTI) A virus that can cause infection in the gut and from there travel to the brain, could be important in the development of Alzheimer's disease, according to a study. Existing antiviral drugs may then be looked at for treating or …

(MENAFN- Investor Brand Network) government showing strong support for bills aimed at treating Alzheimer's disease IGC's leading drug candidate recently completed phase 1 of a safety and tolerability trial, and entered phase 2 Company's …